Recombinant Human B3GNT1 (C-6His)

Description

EnkiLife provides the Recombinant Human B3GNT1 (C-6His) protein,aslo know as N-Acetyllactosaminide Beta-1,3-N-Acetylglucosaminyltransferase,I-Beta-1,3-N-Acetylglucosaminyltransferase,iGnT,Poly-N-Acetyllactosamine Extension Enzyme,UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 1,B3GNT1,B3GNT6, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human N-Acetyllactosaminide Beta-1,3-N-Acetylglucosaminyltransferase is produced by our Mammalian expression system and the target gene encoding Asp43-Cys415 is expressed with a 6His tag at the C-terminus.Accession:O43505. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:43.4 KDa. Background:N-Acetyllactosaminide β-1,3-N-Acetylglucosaminyltransferase (B3GNT1) is a member of the β-1,3-N-Acetylglucosaminyltransferase family. B3GNT1 is a single-pass type II membrane protein and widely expressed in many tissues. B3GNT1 can initiate the synthesis or the elongation of the linear poly-N-acetyllactosaminoglycans. B3GNT1 is essential for the synthesis of poly-N-acetyllactosamine, a determinant for the blood group i antigen. It can initiate the synthesis or the elongation of the linear poly-N-acetyllactosaminoglycans.